346 related articles for article (PubMed ID: 27916939)
21. Pathogenesis of Autoimmune Hepatitis-Cellular and Molecular Mechanisms.
Sirbe C; Simu G; Szabo I; Grama A; Pop TL
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948375
[TBL] [Abstract][Full Text] [Related]
22. Animal models for autoimmune hepatitis.
Christen U; Holdener M; Hintermann E
Autoimmun Rev; 2007 Apr; 6(5):306-11. PubMed ID: 17412303
[TBL] [Abstract][Full Text] [Related]
23. Different sites of xenoantigen delivery lead to a virally induced late-onset hepatitis in mice through molecular mimicry.
Piché C; Béland K; Lapierre P; Massie B; Alvarez F
Liver Int; 2011 Oct; 31(9):1306-14. PubMed ID: 22093453
[TBL] [Abstract][Full Text] [Related]
24. An Update on Animal Models of Autoimmune Hepatitis: Are we There Yet?
Christen U; Hintermann E
Curr Pharm Des; 2015; 21(18):2391-400. PubMed ID: 25777755
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of liver infiltrating CD86-positive mononuclear cells for diagnosis of autoimmune hepatitis.
Kurokohchi K; Masaki T; Himoto T; Deguchi A; Nakai S; Morishita A; Yoneyama H; Kimura Y; Watanabe S; Kuriyama S
World J Gastroenterol; 2006 Apr; 12(16):2523-9. PubMed ID: 16688797
[TBL] [Abstract][Full Text] [Related]
26. [Autoimmune hepatitis].
Sulz MC; Gerlach TJ
Ther Umsch; 2011 Apr; 68(4):189-94. PubMed ID: 21452139
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2.
Mizutani T; Shinoda M; Tanaka Y; Kuno T; Hattori A; Usui T; Kuno N; Osaka T
Drug Metab Rev; 2005; 37(1):235-52. PubMed ID: 15747502
[TBL] [Abstract][Full Text] [Related]
28. Novel therapeutic targets in autoimmune hepatitis.
Taubert R; Hupa-Breier KL; Jaeckel E; Manns MP
J Autoimmun; 2018 Dec; 95():34-46. PubMed ID: 30401504
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis.
Wang Q; Selmi C; Zhou X; Qiu D; Li Z; Miao Q; Chen X; Wang J; Krawitt EL; Gershwin ME; Han Y; Ma X
J Autoimmun; 2013 Mar; 41():140-5. PubMed ID: 23187010
[TBL] [Abstract][Full Text] [Related]
30. The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development.
Hardtke-Wolenski M; Dywicki J; Fischer K; Hapke M; Sievers M; Schlue J; Anderson MS; Taubert R; Noyan F; Manns MP; Jaeckel E
J Autoimmun; 2017 Mar; 78():39-45. PubMed ID: 27974250
[TBL] [Abstract][Full Text] [Related]
31. Adaptive immunity in autoimmune hepatitis.
Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
Dig Dis; 2010; 28(1):63-9. PubMed ID: 20460892
[TBL] [Abstract][Full Text] [Related]
32. Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis.
Nezu S; Tanaka A; Yasui H; Imamura M; Nakajima H; Ishida H; Takahashi S
J Gastroenterol Hepatol; 2006 Sep; 21(9):1448-54. PubMed ID: 16911691
[TBL] [Abstract][Full Text] [Related]
33. The therapeutic effects of Yongdamsagan-tang on autoimmune hepatitis models.
Park J; Kim H; Lee IS; Kim KH; Kim Y; Na YC; Lee JH; Jang HJ
Biomed Pharmacother; 2017 Oct; 94():244-255. PubMed ID: 28763748
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review.
Floreani A; Liberal R; Vergani D; Mieli-Vergani G
J Autoimmun; 2013 Oct; 46():7-16. PubMed ID: 24035197
[TBL] [Abstract][Full Text] [Related]
35. Transient Expression of Transgenic IL-12 in Mouse Liver Triggers Unremitting Inflammation Mimicking Human Autoimmune Hepatitis.
Gil-Farina I; Di Scala M; Salido E; López-Franco E; Rodríguez-García E; Blasi M; Merino J; Aldabe R; Prieto J; Gonzalez-Aseguinolaza G
J Immunol; 2016 Sep; 197(6):2145-56. PubMed ID: 27511737
[TBL] [Abstract][Full Text] [Related]
36. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis.
Djilali-Saiah I; Fakhfakh A; Louafi H; Caillat-Zucman S; Debray D; Alvarez F
J Hepatol; 2006 Dec; 45(6):844-50. PubMed ID: 17050030
[TBL] [Abstract][Full Text] [Related]
37. Requirements and challenges of a preclinical autoimmune hepatitis mouse model.
Hardtke-Wolenski M; Noyan F; Jaeckel E
Dig Dis; 2011; 29(4):402-10. PubMed ID: 21894011
[TBL] [Abstract][Full Text] [Related]
38. Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis.
Lian F; Wang Y; Xiao Y; Wu X; Xu H; Liang L; Yang X
Mol Med Rep; 2015 Oct; 12(4):5821-7. PubMed ID: 26238153
[TBL] [Abstract][Full Text] [Related]
39. Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells.
Hardtke-Wolenski M; Fischer K; Noyan F; Schlue J; Falk CS; Stahlhut M; Woller N; Kuehnel F; Taubert R; Manns MP; Jaeckel E
Hepatology; 2013 Aug; 58(2):718-28. PubMed ID: 23475565
[TBL] [Abstract][Full Text] [Related]
40. Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis.
Fabien N; Desbos A; Bienvenu J; Magdalou J
Autoimmun Rev; 2004 Jan; 3(1):1-9. PubMed ID: 14871643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
